Related Experiment Video
Updated: Jun 2, 2026
16:19
Heterotopic Auxiliary Rat Liver Transplantation With Flow-regulated Portal Vein Arterialization in Acute Hepatic Failure
Published on: September 13, 2014
Acute liver failure and liver assist devices
1Department of Medicine and Surgery, Yale University Medical Center, New Haven, CT, USA. michael.schilsky@yale.edu
Transplantation Proceedings
|April 14, 2011
Summary
Patient survival in acute liver failure (ALF) has improved with earlier recognition and advanced treatments like liver transplantation. Future care may involve liver assist devices, supported by multidisciplinary teams, to enhance patient outcomes.
Area of Science:
- Hepatology
- Critical Care Medicine
- Transplantation Surgery
Background:
- Survival rates for acute liver failure (ALF) have significantly improved over recent decades.
- This progress is attributed to earlier disease detection, enhanced supportive care, and advancements in intensive care units.
- Liver transplantation remains a crucial intervention for patients with ALF.
Purpose of the Study:
- To review the current state of acute liver failure (ALF) management.
- To discuss the potential role of emerging technologies like liver assist devices.
- To emphasize the importance of a multidisciplinary approach in optimizing patient outcomes.
Main Methods:
- Literature review of recent advancements in ALF care.
- Analysis of the impact of supportive measures and intensive care.
- Discussion of the integration of liver assist devices and transplantation.
Main Results:
- Improved survival rates in ALF patients due to earlier recognition and better supportive care.
- Liver transplantation as a key factor in improving long-term outcomes.
- Emerging liver assist devices show promise for bridging patients to recovery or transplant.
Conclusions:
- A multidisciplinary team approach is essential for effective ALF patient management.
- Liver assist devices represent a potential future advancement in ALF treatment.
- Continued advancements in critical care and transplantation are vital for improving ALF patient survival.
Related Concept Videos
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...
01:28Esophageal Varices-II: Clinical Features and Management
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
01:29Hepatic Encephalopathy
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...